312 related articles for article (PubMed ID: 16438855)
21. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
Goya T; Asamura H; Yoshimura H; Kato H; Shimokata K; Tsuchiya R; Sohara Y; Miya T; Miyaoka E;
Lung Cancer; 2005 Nov; 50(2):227-34. PubMed ID: 16061304
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
25. Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer.
Nomori H; Ikeda K; Mori T; Kobayashi H; Iwatani K; Kawanaka K; Shiraishi S; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):780-5. PubMed ID: 17320584
[TBL] [Abstract][Full Text] [Related]
26. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.
Pfannschmidt J; Muley T; Bülzebruck H; Hoffmann H; Dienemann H
Lung Cancer; 2007 Mar; 55(3):371-7. PubMed ID: 17123661
[TBL] [Abstract][Full Text] [Related]
27. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
28. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer.
Okada M; Sakamoto T; Yuki T; Mimura T; Miyoshi K; Tsubota N
Ann Thorac Surg; 2006 Mar; 81(3):1028-32. PubMed ID: 16488715
[TBL] [Abstract][Full Text] [Related]
29. Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results.
Grodzki T; Alchimowicz J; Kozak A; Kubisa B; Pieróg J; Wójcik J; Bielewicz M; Witkowska D
Eur J Cardiothorac Surg; 2008 Sep; 34(3):493-8. PubMed ID: 18583143
[TBL] [Abstract][Full Text] [Related]
30. Effects of reclassification from the TNM-6 into the TNM-7 staging system in bronchoplastic resection for non-small cell lung cancer.
Klikovits T; End A; Riedl G; Stiebler M; Dekan G; Klepetko W
Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):29-34. PubMed ID: 21525027
[TBL] [Abstract][Full Text] [Related]
31. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations.
Asamura H; Goya T; Koshiishi Y; Sohara Y; Tsuchiya R; Miyaoka E;
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):316-9. PubMed ID: 16872956
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival.
Veeramachaneni NK; Battafarano RJ; Meyers BF; Zoole JB; Patterson GA
Eur J Cardiothorac Surg; 2008 Mar; 33(3):466-9. PubMed ID: 18249130
[TBL] [Abstract][Full Text] [Related]
33. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
34. Clinically predictive factors of pathologic upstaging in patients with peripherally located clinical stage IA non-small cell lung cancer.
Yamazaki K; Yoshino I; Yohena T; Kameyama T; Tagawa T; Kawano D; Oba T; Koso H; Maehara Y
Lung Cancer; 2007 Mar; 55(3):365-9. PubMed ID: 17267071
[TBL] [Abstract][Full Text] [Related]
35. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?
Chamogeorgakis T; Anagnostopoulos C; Kostopanagiotou G; Bhora F; Toumpoulis I; Georgiannakis E; Nabong A; Dosios T; Harrison L; Connery C
Thorac Cardiovasc Surg; 2008 Apr; 56(3):148-53. PubMed ID: 18365973
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes after a variety of video-assisted thoracoscopic lobectomy approaches for clinical stage IA lung cancer: a multi-institutional study.
Shigemura N; Akashi A; Funaki S; Nakagiri T; Inoue M; Sawabata N; Shiono H; Minami M; Takeuchi Y; Okumura M; Sawa Y
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):507-12. PubMed ID: 16935102
[TBL] [Abstract][Full Text] [Related]
37. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917
[TBL] [Abstract][Full Text] [Related]
38. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
39. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
40. [Choice of examination methods in bronchial cancer].
Leuenberger P
Helv Chir Acta; 1990 Jan; 56(5):701-10. PubMed ID: 2182571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]